0001474064-11-000017.txt : 20110523
0001474064-11-000017.hdr.sgml : 20110523
20110523160413
ACCESSION NUMBER: 0001474064-11-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110519
FILED AS OF DATE: 20110523
DATE AS OF CHANGE: 20110523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRANADILLO PEDRO P
CENTRAL INDEX KEY: 0001217544
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23272
FILM NUMBER: 11865086
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000890465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 870439579
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: (908) 450-5300
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
edgar.xml
PRIMARY DOCUMENT
X0303
4
2011-05-19
0000890465
NPS PHARMACEUTICALS INC
NPSP
0001217544
GRANADILLO PEDRO P
550 HILLS DRIVE
BEDMINSTER
NJ
07921
1
0
0
0
Deferred Stock Units
2011-05-19
4
A
0
756
0
A
Common Stock
756
4346
D
Each Deferred Stock Unit represents a right to receive one share of NPS Common Stock.
Deferred Stock Units awarded under the NPS Pharmaceuticals, Inc. 2007 Nonemployee Directors' Compensation Program will be settled in NPS Common Stock upon (1) separation from service on the Board, (2) death, (3) disability, or (4) sale of substantially all the assets of the Company.
/s/ Edward Stratemeier as Attorney-in-fact
2011-05-23